Healthcare >> CEO Interviews >> October 17, 2003

Donald Kiepert Jr. – Point Therapeutics Inc (potp)

DONALD R. KIEPERT JR. has served since 1997 as Chairman of the Board, President and Chief Executive Officer of Point Therapeutics, Inc., a Boston-based publicly traded biopharmaceutical company. He also serves as Chairman of the Board of Pericor Sciences, Celadon Science and Sunalert Inc. From 1989 to 1996 he was President and Chief Executive Officer of Chartwell Home Therapies, a national home infusion services company. Mr. Kiepert has also started and managed several healthcare companies and worked in various management positions at Baxter Travenol, Inc. In addition to his numerous business interests, he is a member of the Board of Governors of Nashawtuc Country Club and a member of the Board of Visitors for the Walnut Hill Performing Arts School. Mr. Kiepert received a BS in Pharmacy and an MS in Clinical Pharmacy from Purdue University. Profile
TWST: Would you begin with a history and overview of Point Therapeutics?

Mr. Kiepert: The company was founded in the fourth quarter of 1996,

based on technology that we licensed from Tufts